ROI Factor In today's competitive business climate, every operational decision must be made with consideration of the investment and the return on that investment. For companies that are inundated by ...

India generates about 20% of the world’s digital data but is home to only 3% of its data-centre capacity. At the same time, India’s policy aim is to have all sensitive data generated on Indian ...

An Nvidia NVDA2.81%increase; green up pointing triangle-backed AI startup is planning to build a massive data-center complex with CoreWeave CRWV 2.65%increase; green up pointing triangle that is ...

India’s grand ambition to build up renewable energy capacity may stub its toe on a hidden factor – lack of enough data. There is little disagreement in the renewable energy industry on this point. You ...

In early October 2025, Intellia Therapeutics presented new clinical results at the European Society of Gene & Cell Therapy Congress, highlighting long-term safety and efficacy data for its ...

For decades, America’s voter roll maintenance system has been running on fumes. It still relies on tools like the Postal Service’s National Change of Address database and the Social Security Death ...

Salesforce Inc. has introduced a collection of new tools designed to support customers’ artificial intelligence initiatives. The first set of features, which debuted today, will help organizations ...

An analysis suggests two Wisconsin data centers could use more energy than all the state's homes combined. The estimate assumes constant power demand, so actual usage may be lower. Three other ...

The average U.S. household now has 21 different devices connected to the internet, enabling everything from computers and cell phones to smart lighting and appliances. Beyond personal uses, ...

Artificial intelligence has notorious problems with accuracy — so maybe it’s not surprising that using it as a coding assistant creates more security problems, too. As a security firm called Apiiro ...

Wave Life Sciences (NASDAQ:WVE) lost ~21% in the premarket on Wednesday after the company announced data from a Phase 1b/2a trial for its RNA-editing therapy WVE-006 developed with GSK (NYSE:GSK) for ...

The world runs on data. A hallmark of successful businesses is their ability to use quality facts and figures to their advantage. Unfortunately, data rarely arrives ready to use. Instead, businesses ...